Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) EBITDA Margin: 2021-2024

Historic EBITDA Margin for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -46.11%.

  • Biofrontera's EBITDA Margin fell 3480.00% to -89.84% in Q3 2025 from the same period last year, while for Sep 2025 it was -47.40%, marking a year-over-year increase of 736.00%. This contributed to the annual value of -46.11% for FY2024, which is 2044.00% up from last year.
  • As of FY2024, Biofrontera's EBITDA Margin stood at -46.11%, which was up 30.72% from -66.56% recorded in FY2023.
  • Biofrontera's EBITDA Margin's 5-year high stood at -46.11% during FY2024, with a 5-year trough of -104.57% in FY2021.
  • Over the past 3 years, Biofrontera's median EBITDA Margin value was -64.80% (recorded in 2022), while the average stood at -59.16%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first surged by 3,977bps in 2022, then slumped by 176bps in 2023.
  • Biofrontera's EBITDA Margin (Yearly) stood at -104.57% in 2021, then soared by 3,977bps to -64.80% in 2022, then slumped by 176bps to -66.56% in 2023, then skyrocketed by 2,044bps to -46.11% in 2024.